| Bioactivity | MIF-1 TFA (Melanostatin), an endogenous brain peptide, is a potent dopamine receptor allosteric modulator. MIF-1 TFA inhibits melanin formation. MIF-1 TFA blocks the effects of opioid receptor activation to modulate the analgesic effects. MIF-1 TFA accesses from the blood to the CNS by directly crossing the blood-brain barrier (BBB)[1][2][3]. | ||||||
| Invitro | MIF-1 TFA (Melanostatin, 1 μM) provokes a reversible hyperpolarization and a suppression of spontaneous action potentials[2]. | ||||||
| Name | MIF-1 TFA | ||||||
| CAS | 35240-69-8 | ||||||
| Formula | C15H25F3N4O5 | ||||||
| Molar Mass | 398.38 | ||||||
| Transport | Room temperature in continental US; may vary elsewhere. | ||||||
| Storage | Sealed storage, away from moisture and light
*In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture and light) |
MIF-1 TFA
CAS: 35240-69-8 F: C15H25F3N4O5 W: 398.38
MIF-1 TFA (Melanostatin), an endogenous brain peptide, is a potent dopamine receptor allosteric modulator. MIF-1 TFA inh
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.